MARKET

ATEC

ATEC

Alphatec Hldg
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.74
-0.40
-2.83%
Closed 16:07 09/24 EDT
OPEN
13.97
PREV CLOSE
14.14
HIGH
14.09
LOW
13.68
VOLUME
712.90K
TURNOVER
--
52 WEEK HIGH
19.36
52 WEEK LOW
6.11
MARKET CAP
1.38B
P/E (TTM)
-10.3409
1D
5D
1M
3M
1Y
5Y
ATEC to Feature Comprehensive Procedural Solutions at NASS 2021
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company's comprehensive procedural portfolio will be featured at the North American Spine Societ...
Business Wire · 09/15 20:05
ATEC to Participate in Upcoming Investor Conferences
CARLSBAD, Calif., August 30, 2021--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that Pat Miles, Chairman and Chief Executive Officer, an...
Business Wire · 08/30 13:00
Needham Initiates Coverage On Alphatec Holdings with Buy Rating, Announces Price Target of $18
Needham analyst David Saxon initiates coverage on Alphatec Holdings (NASDAQ:ATEC) with a Buy rating and announces Price Target of $18.
Benzinga · 08/25 10:24
Needham Starts Alphatec Holdings at Buy With $18 Price Target
MT Newswires · 08/25 06:53
Return on Capital Employed Insights for Alphatec Holdings
After pulling data from Benzinga Pro it seems like during Q2, Alphatec Holdings (NASDAQ:ATEC) brought in sales totaling $62.25 million. However, earnings decreased 87.71%, resulting in a loss of $35.75 million.
Benzinga · 08/20 17:41
Insider Trends: Insider at Alphatec Holdings Converts Options in Mist of 90-Day Buying Trend
MT Newswires · 08/09 11:35
Insider Trends: Insider at Alphatec Holdings Sells Stock for Taxes Interrupting 90-Day Buy Trend
MT Newswires · 08/09 11:33
Alphatec prices upsized $275M convertible notes offering
Alphatec Holdings (NASDAQ:ATEC) has priced its upsized offering of $275M of 0.75% convertible senior notes due 2026 (from $250) in a private offering. Initial purchasers are ranted an option to
Seekingalpha · 08/06 07:32
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ATEC. Analyze the recent business situations of Alphatec Hldg through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ATEC stock price target is 21.81 with a high estimate of 26.00 and a low estimate of 18.00.
EPS
Institutional Holdings
Institutions: 191
Institutional Holdings: 46.99M
% Owned: 46.93%
Shares Outstanding: 100.12M
TypeInstitutionsShares
Increased
60
5.44M
New
21
1.34M
Decreased
43
3.11M
Sold Out
24
2.84M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.61%
Healthcare Equipment & Supplies
-0.42%
Key Executives
Chairman/President/Chief Executive Officer/Director
Patrick Miles
Chief Financial Officer/Executive Vice President
J. Todd Koning
Executive Vice President/General Counsel
Craig Hunsaker
Executive Vice President/Director of Sales
David Sponsel
Executive Vice President/Director of Marketing
Brian Snider
Executive Vice President
Eric Dasso
Executive Vice President
Kelli Howell
Executive Vice President
Mark Ojeda
Senior Vice President
Scott Lish
Lead Director/Independent Director
Mortimer Berkowitz
Director
Jeffrey Rydin
Independent Director
Beth Altman
Independent Director
Evan Bakst
Independent Director
Quentin Blackford
Independent Director
Jason Hochberg
Independent Director
Karen McGinnis
Independent Director
Marie Meynardier
Independent Director
David Mowry
Independent Director
David Pelizzon
Independent Director
James Tullis
Independent Director
Ward Woods
No Data
About ATEC
Alphatec Holdings, Inc. is a medical technology company. The Company, through its subsidiary, Alphatec Spine, Inc., and its subsidiaries, designs, develops, manufactures, and markets products for the surgical treatment of spine disorders. The Company offers Organic Innovation Machine, which is focused on developing technology to treat spine’s various pathologies. The Company provides multiple lordosis and footprint options to accommodate varying surgical requirements across all interbody fusion procedures including ACDF, ALIF, LIF, PLIF, and TLIF. The Company’s subsidiaries include Alphatec Spine, Inc., Alphatec Holdings International C.V., Scient'x S.A.S., and Surgiview S.A.S., HealthpointCapital, LLC, HealthpointCapital Partners, L.P., HealthpointCapital Partners II, L.P., John H. Foster and Mortimer Berkowitz III, and Orthotec, LLC and Patrick Bertranou.

Webull offers kinds of Alphatec Holdings Inc stock information, including NASDAQ:ATEC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATEC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ATEC stock methods without spending real money on the virtual paper trading platform.